EIF1AX |
P47813
|
eukaryotic translation initiation factor 1A X-linked
|
Nucleic acid binding
|
0.91 |
0.716 |
0.231 |
SDCBP |
O00560
|
syndecan binding protein
|
Transporter
|
5.8E-04 |
0.653 |
0.385 |
CYSLTR2 |
Q9NS75
|
cysteinyl leukotriene receptor 2
|
G-protein coupled receptor
|
1.0E-04 |
0.633 |
0.538 |
RAB8A |
P61006
|
RAB8A, member RAS oncogene family
|
|
0.98 |
0.610 |
0.577 |
PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
CD160 |
O95971
|
CD160 molecule
|
|
6.8E-05 |
0.590 |
0.615 |
MLANA |
Q16655
|
melan-A
|
|
1.3E-09 |
0.579 |
0.692 |
MCAM |
P43121
|
melanoma cell adhesion molecule
|
Cell adhesion
|
1.6E-04 |
0.514 |
0.731 |
TRIO |
O75962
|
trio Rho guanine nucleotide exchange factor
|
Kinase
|
1.00 |
0.556 |
0.731 |
BAP1 |
Q92560
|
BRCA1 associated protein 1
|
Enzyme
|
0.99 |
0.454 |
0.731 |
MRPL28 |
Q13084
|
mitochondrial ribosomal protein L28
|
|
2.0E-07 |
0.505 |
0.731 |
NXT1 |
Q9UKK6
|
nuclear transport factor 2 like export factor 1
|
|
0.65 |
0.505 |
0.731 |
RMC1 |
Q96DM3
|
regulator of MON1-CCZ1
|
|
0.99 |
0.555 |
0.731 |
LOC110806263 |
|
TERT 5' regulatory region
|
|
|
0.464 |
0.731 |
H3P9 |
|
H3 histone pseudogene 9
|
|
|
0.505 |
0.731 |
BMP7 |
P18075
|
bone morphogenetic protein 7
|
Signaling
|
0.13 |
0.498 |
0.769 |
CD47 |
Q08722
|
CD47 molecule
|
|
0.92 |
0.468 |
0.769 |
CDK9 |
P50750
|
cyclin dependent kinase 9
|
Kinase
|
8.9E-05 |
0.498 |
0.769 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
MIA |
Q16674
|
MIA SH3 domain containing
|
|
1.7E-05 |
0.537 |
0.769 |
B3GAT1 |
Q9P2W7
|
beta-1,3-glucuronyltransferase 1
|
Enzyme
|
0.14 |
0.494 |
0.769 |
XIAP |
P98170
|
X-linked inhibitor of apoptosis
|
Enzyme modulator
|
0.92 |
0.447 |
0.808 |
CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |